161
Views
3
CrossRef citations to date
0
Altmetric
Oncology

Impact of positron emission tomography with the use of fluorodeoxyglucose on response to induction chemotherapy in patients with oropharyngeal and hypopharyngeal squamous cell carcinoma

, , , , , , , & show all
Pages 523-530 | Received 03 Jul 2012, Accepted 16 Sep 2012, Published online: 17 May 2013

References

  • Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893–917.
  • Tanaka S, Sobue T. Comparison of oral and pharyngeal cancer mortality in five countries: France, Italy, Japan, UK and USA from the WHO Mortality Database (1960-2000). Jpn J Clin Oncol 2005;35:488–91.
  • Seiwert TY, Cohen EE. State-of-the-art management of locally advanced head and neck cancer. Br J Cancer 2005;92:1341–8.
  • Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med 2001;345:1890–900.
  • Mehanna H, West CM, Nutting C, Paleri V. Head and neck cancer –. Part 2: Treatment and prognostic factors. BMJ 2010;341:c4690.
  • Brun E, Ohlsson T, Erlandsson K, Kjellen E, Sandell A, Tennvall J, Early prediction of treatment outcome in head and neck cancer with 2-18FDG PET. Acta Oncol 1997;36:741–7.
  • Oshida M, Uno K, Suzuki M, Nagashima T, Hashimoto H, Yagata H, Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro18F]-D-glucose. Cancer 1998;82:2227–34.
  • Vansteenkiste JF, Stroobants SG, Dupont PJ, De Leyn PR, Verbeken EK, Deneffe GJ, Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: an analysis of 125 cases. Leuven Lung Cancer Group. J Clin Oncol 1999;17:3201–6.
  • Allal AS, Dulguerov P, Allaoua M, Haenggeli CA, El-Ghazi el A, Lehmann W, Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy. J Clin Oncol 2002;20:1398–404.
  • Wong RJ, Lin DT, Schoder H, Patel SG, Gonen M, Wolden S, Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 2002;20:4199–208.
  • Suzuki H, Fukuyama R, Hasegawa Y, Tamaki T, Nishio M, Nakashima T, Tumor thickness, depth of invasion, and Bcl-2 expression are correlated with FDG-uptake in oral squamous cell carcinomas. Oral Oncol 2009;45:891–7.
  • Higgins KA, Hoang JK, Roach MC, Chino J, Yoo DS, Turkington TG, Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value. Int J Radiat Oncol Biol Phys 2012;82:548–53.
  • Querellou S, Abgral R, Le Roux PY, Nowak E, Valette G, Potard G, Prognostic value of fluorine-18 fluorodeoxyglucose positron-emission tomography imaging in patients with head and neck squamous cell carcinoma. Head Neck 2012;34:462–8.
  • Warburg O. On the origin of cancer cells. Science 1956;123:309–14.
  • Garber K. Energy boost: the Warburg effect returns in a new theory of cancer. J Natl Cancer Inst 2004;96:1805–6.
  • Oriuchi N, Higuchi T, Ishikita T, Miyakubo M, Hanaoka H, Iida Y, Present role and future prospects of positron emission tomography in clinical oncology. Cancer Sci 2006;97:1291–7.
  • Reisser C, Eichhorn K, Herold-Mende C, Born AI, Bannasch P. Expression of facilitative glucose transport proteins during development of squamous cell carcinomas of the head and neck. Int J Cancer 1999;80:194–8.
  • Friedman M, Grey P, Venkatesan TK, Bloch I, Chawla P, Caldarelli DD, Prognostic significance of Bcl-2 expression in localized squamous cell carcinoma of the head and neck. Ann Otol Rhinol Laryngol 1997;106:445–50.
  • Hsu PK, Lin KH, Wang SJ, Huang CS, Wu YC, Hsu WH. Preoperative positron emission tomography/computed tomography predicts advanced lymph node metastasis in esophageal squamous cell carcinoma patients. World J Surg 2011;35:1321–6.
  • Omloo JM, van Heijl M, Hoekstra OS, van Berge Henegouwen MI, van Lanschot JJ, Sloof GW. FDG-PET parameters as prognostic factor in esophageal cancer patients: a review. Ann Surg Oncol 2011;18:3338–52.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.